Pembrolizumab (MK-3475) in MM Patients With Residual Disease
Clinical trial NCT02636010 · COMPLETED
Trial details
- NCT number
- NCT02636010
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.